Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Cypherpunk Technologies ( (CYPH) ) has issued an update.
On December 30, 2025, Cypherpunk Technologies announced it had purchased an additional 56,418.09 Zcash tokens for about $29 million at an average price of $514.02 per ZEC, significantly expanding its crypto treasury. This latest transaction lifted the company’s total ZEC holdings to 290,062.67 tokens, acquired at an average cost of $334.41 per ZEC and representing an estimated 1.76% of Zcash’s circulating supply, underscoring Cypherpunk’s aggressive strategy to accumulate a substantial share of the privacy-focused cryptocurrency as part of its broader positioning in privacy technologies and its bid to enhance long-term shareholder value.
The most recent analyst rating on (CYPH) stock is a Hold with a $1.25 price target. To see the full list of analyst forecasts on Cypherpunk Technologies stock, see the CYPH Stock Forecast page.
Spark’s Take on CYPH Stock
According to Spark, TipRanks’ AI Analyst, CYPH is a Neutral.
The score is held back mainly by weak financial quality—large losses and sustained cash burn despite improving revenue—while low leverage supports the balance sheet. Technical signals are mixed (stronger longer-term trend but weaker near-term momentum), valuation is constrained by negative earnings, and recent corporate actions are a mix of compliance positives and dilution/reverse-split risk.
To see Spark’s full report on CYPH stock, click here.
More about Cypherpunk Technologies
Cypherpunk Technologies Inc., formerly Leap Therapeutics, is a privacy-focused technology company that implements a digital asset treasury strategy anchored by Zcash while also developing novel cancer therapies through its Leap Therapeutics subsidiary. The company aims to build long-term shareholder value by acquiring and participating in the development of ZEC and by advancing its oncology pipeline, including sirexatamab and FL-501, targeting patients with cancer.
Average Trading Volume: 26,581,000
Technical Sentiment Signal: Hold
Current Market Cap: $67.98M
Learn more about CYPH stock on TipRanks’ Stock Analysis page.